Project Aim

Photoreceptors are the light-sensing cells in the retina that enable vision. The loss of photoreceptors is a key hallmark of many degenerative eye diseases, including Retinitis Pigmentosa (RP) which affects >1 million people worldwide. While some options exist to forestall such photoreceptor degeneration, there are no effective means to cure blindness once photoreceptors are lost.

Cell reprogramming technology could change this, restoring vision by regenerating these lost cells. This technology allows us to convert cells from one type into another by activating certain key genes. This gives us a unique opportunity to generate photoreceptors in the lab, and the exciting possibility of regenerating photoreceptors in the patient’s eye to restore vision.

To harness this potential, this project aimed to develop cell reprogramming technology that targets the stem cells within the retina (the Müller glial cells) to regenerate into photoreceptors.

Project Results and Impact

Firstly, we built a world’s first human retina gene atlas at single cell resolution. This atlas provided the crucial genetic information to develop cell reprogramming method to target Müller glial cells to regenerate photoreceptors. Using this knowledge, we successfully developed a cell reprogramming method to generate human photoreceptors in a lab dish.

Detailed characterisation of the derived photoreceptors showed that they expressed the right marker genes and proteins and are functional in light detection, providing supporting evidence to the feasibility of our reprogramming method to generate human photoreceptors. Also, we tested the feasibility of our cell reprogramming technology in rodent models. We developed a linage tracing system that allowed us to identify newly regenerated photoreceptors within the rodent’s eye, and obtained pilot safety data for application of cell reprogramming technology in rodents. We are in the process of analysing the efficacy of using cell reprogramming for photoreceptor regeneration in rodents.

The team is truly grateful to the generous support from Retina Australia to advance this project. Overall, our findings provided new insights into the genetic signal that enables vision, and have paved the way to develop cell reprogramming technology as a novel regenerative therapy to treat photoreceptor losses. This would have direct implications in treating RP, as well as other blinding diseases with photoreceptor losses such as Age-Related Macular degeneration and Stargardt’s disease.


This project was featured in one of Retina Australia’s 2021 webinars.  You can view a recording of this event here.

Chief investigator:
Raymond Wong
Centre for Eye Research Australia, University of Melbourne


Professor Keith Martin, Centre for Eye Research Australia, Melbourne

Dr Carla Abbott, Centre for Eye Research Australia, Melbourne

Grant awarded:
$40,000 (2020)

Research Impact Reports

Improving real-world mobility and assessing long-term safety outcomes with a retinal prosthesis (“Bionic Eye”)

Project Aim This project aimed to measure visual outcomes of...

RNA base editing strategies as potential therapeutic of inherited retinal dystrophies

Project Aim This study aimed to use a new genetic...

Neuroprotective effect of SAHA in Retinitis Pigmentosa. Do time and frequency matter?

Project Aim Retinitis Pigmentosa (RP) is a genetic, blinding retinal...

Improving Sensory Substitution Low Vision Devices Through Novel Software Adaptations

Project Aim To investigate the efficacy of sensory substitution devices...